Qlarant Capital

Overview

Qlarant Capital is the corporate venture capital arm of Qlarant Inc., established to invest in early-stage healthcare startups. The firm leverages Qlarant's extensive experience in healthcare solutions and tech-enabled services to support innovative companies in the healthcare sector. By providing funding and strategic guidance, Qlarant Capital aims to foster growth and innovation in the industry. The firm's investment strategy focuses on early-stage startups in the healthcare industry, with check sizes ranging from $50,000 to $2 million. Qlarant Capital offers support as a value-add investor, providing expertise in product development, machine learning engineering, executive recruiting, sales and marketing, and regulatory compliance guidance. This comprehensive approach helps portfolio companies navigate the complexities of the healthcare market and achieve sustainable growth. Qlarant Capital's portfolio includes investments in companies such as AgileDD, an enterprise AI company based in Houston, Texas, and InpharmD™, an Atlanta-based provider of AI-driven drug information services. These investments reflect Qlarant Capital's commitment to supporting innovative solutions that enhance healthcare delivery and patient outcomes. By backing daring entrepreneurs, Qlarant Capital contributes to building the future of healthcare through technology and collaboration.

Investment Focus

• Early-stage healthcare startups seeking funding between $50,000 and $2 million.

Portfolio Companies